Retinoic acid inhibits in vitro development of mast cells but has no marked effect on mature human skin tryptase- and chymase-positive mast cells

Journal of Investigative Dermatology

Volumn 120, Issue 2, 2003, Pages 239-245

  Hjertson, Malin ^a   Kivinen, Petri K ^b   Dimberg, Lina ^a   Nilsson, Kenneth ^a   Harvima, Ilkka T ^b   Nilsson, Gunnar ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Differentiation; Hematopoiesis; Stem cell factor; Tryptase

Indexed keywords

CHYMASE; NOVALAN; RETINOIC ACID; RETINOIC ACID RECEPTOR; STEM CELL FACTOR; TRYPTASE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; RETINOID X RECEPTOR; SERINE PROTEINASE; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; CREAM; DRUG EFFECT; FEMALE; HEMATOPOIESIS; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; MALE; MAST CELL; NORMAL HUMAN; PRIORITY JOURNAL; STEM CELL; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; CELL LINEAGE; CHEMISTRY; CYTOLOGY; DIMERIZATION; ENZYMOLOGY; METABOLISM; ORGAN CULTURE TECHNIQUE; SKIN;

ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINEAGE; CELLS, CULTURED; CHYMASES; DIMERIZATION; HUMANS; MAST CELLS; ORGAN CULTURE TECHNIQUES; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; SERINE ENDOPEPTIDASES; SKIN; STEM CELL FACTOR; STEM CELLS; TRANSCRIPTION FACTORS; TRETINOIN; TRYPTASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037318128     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12030.x     Document Type: Article

References (43)

1. Ackermann L, Harvima IT: Mast cells of psoriatic and atopic dermatitis skin are positive for TNF-α and their degranulation is associated with expression of ICAM-1 in the epidermis. Arch Dermatol Res 290:353-359, 1998
2. Bradley EC, Ruscetti FW, Steinberg H, Paradise C, Blaine K: Inhibition of differentiation and proliferation of colony-stimulating factor-induced clonal growth of normal human marrow cells in vitro by retinoic acid. J Natl Cancer Inst 71:1189-1192, 1983
3. Butterfield JH, Weiler D, Dewald G, Gleich GJ: Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 12:345-355, 1988
4. Costa JJ, Demetri GD, Harrist TJ, et al: Recombinant human stem cell factor (Kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med 183:2681-2686, 1996
5. Douer D, Koeffler HP: Retinoic acid enhances colony-stimulating factor-induced clonal growth of normal human myeloid progenitor cells in vitro. Exp Cell Res 138:193-198, 1982
6. Du ZM, Li YL, Xia HZ, Irani AM, Schwartz LB: Recombinant human granulocyte-macrophage colony-stimulating factor (CSF), but not recombinant human granulocyte CSF, down-regulates the recombinant human stem cell factor-dependent differentiation of human fetal liver-derived mast cells. J Immunol 159:838-845, 1997
7. Eichelberg D, Schmutzler W: Synthetic retinoids inhibit histamine release from isolated human mast cells. Arch Dermatol Res 280:155-157, 1988
8. Fahlman C, Jacobsen SE, Smeland EB, Lomo J, Naess CE, Funderud S, Blomhoff HK: All-trans- and 9-cis-retinoic acid inhibit growth of normal human and routine B cell precursors. J Immunol 155:58-65, 1995
9. Födinger M, Fritsch G, Emminger W, Mitterbauer G, Gadner H, Valent P, Mannhalter C: Origin of human mast cells: development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation. Blood 84:2954-2959, 1994
10. Giguere V, Ong ES, Segui P, Evans RM: Identification of a receptor for the morphogen retinoic acid. Nature 330:624-629, 1987
11. Gratas C, Menot ML, Dresch C, Chomienne C: Retinoid acid supports granulocytic but not erythroid differentiation of myeloid progenitors in normal bone marrow cells. Leukemia 7:1156-1162, 1993
12. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, Thaller C: 9-cis-retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68:397-406, 1992
13. Hjertson M, Sundström C, Nilsson K, Nilsson G: The potential of human mast cell progenitors to differentiate into mature mast cells remains after prolonged culture with flt3 ligand, interleukin-3, or granulocyte-macrophage colony stimulating factor. Br J Hematol 104:516-522, 1999
14. TC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem 37:1509-1515, 1989
15. Irani AA, Nilsson G, Miettinen U, et al: Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 80:3009-3021, 1992
16. Jacobsen SEW, Fahlman C, Blomhoff HK, Okkenhaug C, Rusten LS, Smeland EB: All-trans- and 9-cis-retinoic acid: potent direct inhibitors of primitive routine hematopoietic progenitors in vitro. J Exp Med 179:1665-1670, 1994
17. Järvikallio A, Naukkarinen A, Harvima IT, Aalto ML, Horsmanheimo M: Quantitative analysis of tryptase- and chymase-containing mast cells in atopic dermatitis and nummular eczema. Br J Dermatol 136:871-877, 1997
18. Kinoshita T, Koike K, Mwamtemi HH, et al: Retinoic acid is a negative regulator for the differentiation of cord blood-derived human mast cell progenitors. Blood 95:2821-2828, 2000
19. Kirshenbaum AS, Kessler SW, Goff JP, Metcalfe DD: Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J Immunol 146:1410-1415, 1991
20. Kirshenbaum AS, Worobec AS, Davis TA, Goff JP, Semere T, Metcalfe DD: Inhibition of human mast cell growth and differentiation by interferon-γ-1b. Exp Hematol 26:245-251, 1998
21. Kivinen PK, Kaminska R, Naukkarinen A, Harvima RJ, Horsmanheimo M, Harvima IT: Release of soluble tryptase but only minor amounts of chymase activity from cutaneous mast cells. Exp Dermatol 10:246-255, 2001
22. Kivinen PK, Nilsson G, Naukkarinen A, Harvima IT: Mast cell survival and apoptosis in organ-cultured human skin. Exp Dermatol in press: 2003
23. Lehmann JM, Jong L, Fanjul A, et al: Retinoids selective for retinoid X receptor response pathways. Science 258:1944-1946, 1992
24. Liu M, Iavarone A, Freedman LP: Transcriptional activation of the human p21 (WAF1/C1P1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J Biol Chem 271:31723-31728, 1996
25. Lotan R: Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim Biophys Acta 605:33-91, 1980
26. Lucek RW, Colburn WA: Clinical pharmacokinetics of the retinoids. Clin Pharmacokinet 10:38-62, 1985
27. Mangelsdorf DJ, Evans RM: The RXR heterodimers and orphan receptors. Cell 83:841-850, 1995
28. Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM: Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345:224-229, 1990
29. Mitsui H, Furitsu T, Dvorak AM, et al: Development of human mast cells from umbilical cord blood cells by recombinant human and routine c-kit ligand. Proc Natl Acad Sci USA 90:735-739, 1993
30. Nagler A, Riklis I, Kletter Y, Tatarsky I, Fabian I: Effect of 1,25 dihydroxyvitamin D3 and retinoic acid on normal human pluripotent (CFU-mix), erythroid (BFU-E), and myeloid (CFU-C) progenitor cell growth and differentiation patterns. Exp Hematol 14:60-65, 1986
31. Nilsson G, Blom T, Kusche GM, et al: Phenotypic characterization of the human mast cell line HMC-1. Scand J Immunol 39:489-498, 1994a
32. Nilsson G, Miettinen U, Ishizaka T, Irani AM, Schwartz LB: IL-4 inhibits the expression of Kit and tryptase during the stem cell factor-dependent development of human mast cells from fetal liver cells. Blood 84:1519-1527, 1994b
33. Nilsson G, Nilsson K: Effects of IL-13 on immediate-early response gene expression, phenotype and differentiation of human mast cells. Comparision with IL-4. Eur J Immunol 25:870-873, 1995
34. Paul CC, Mahrer S, Tolbert M, Elbert BL, Wong I, Ackerman SJ, Baumann MA: Changing the differentiation program of hematopoietic cells: retinoic acid-induced shift of eosinophil-committed cells to neutrophils. Blood 86:3737-3744, 1995
35. Petkovich M, Brand NJ, Krust A, Chambon P: A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330:444-450, 1987
36. Purton LE, Bernstein ID, Collins SJ: All- trans retinoic acid delays the differentiation of primitive hematopoietic precursors (lin-c-kit + Sca-1 (+)) while enhancing the terminal maturation of committed granulocyte/monocyte progenitors. Blood 94:483-495, 1999
37. 2 from cord blood mononuclear cells. J Immunol 157:343-350, 1996
38. Sawai N, Koike K, Mwamtemi HH, et al: Thrombopoietin augments stem cell factor-dependent growth of human mast cells from bone marrow multipotential hematopoictic progenitors. Blood 93:3703-3712, 1999
39. Sillaber C, Sperr WR, Agis H, Spanblöchl E, Lechner K, Valent P: Inhibition of stem cell factor dependent formation of human mast cells by interleukin-3 and interleukin-4. Int Arch Allergy Immunol 105:264-268, 1994
40. Tsai S, Bartelmez S, Heyman R, Datum K, Evans R, Collins SJ: A mutated retinoic acid receptor-α exhibiting dominant-negative activity alters the lineage development of a multipotent hematopoietic cell line. Genes Dev 6:2258-2269, 1992
41. Upham JW, Sehmi R, Hayes LM, Howie K, Luodahl J, Denburg JA: Retinoic acid modulates IL-5 receptor expression and selectively inhibits eosinophil-basophil differentiation of hemopoietic progenitor cells. J Allergy Clin Immunol 109:307-313, 2002
42. Valent P, Spanblöchl E, Sperr WR, et al: Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/Kit-ligand in long-term culture. Blood 80:2237-2245, 1992
43. Zhang XK, Lehmann J, Hoffmann B, et al: Homodimer formation of retinoid X receptor induced by 9- cis retinoic acid. Nature 358:587-591, 1992